GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
Cited 8 time in
- Title
- GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
- Author(s)
- K S Hong; J H Ahn; J G Jang; J H Lee; H N Kim; D Kim; Wonhwa Lee
- Bibliographic Citation
- Signal Transduction and Targeted Therapy, vol. 5, pp. 267-267
- Publication Year
- 2020
- ISSN
- 2095-9907
- Publisher
- Springer-Nature Pub Group
- Full Text Link
- http://dx.doi.org/10.1038/s41392-020-00391-5
- Type
- Article
- Appears in Collections:
- 1. Journal Articles > Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.